Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 14, 2009

Roche Gains Access to Cerep’s Pharmacology and ADME Database

  • Roche has inked a deal to use Cerep’s BioPrint®, a homogenous pharmacology and ADME database. The BioPrint database is composed of three main data sets: chemical descriptors (structures and chemical information, 2-D and 3-D descriptors), in vitro profiles, and in vivo effects of tested compound.

    Cerep will also generate new BioPrint® data on Roche compounds for Roche’s exclusive use. Additionally, the companies will collaborate on further development of BioPrint® and related pharmaco-informatics tools aimed at predicting as early as possible adverse drug reactions that could lead to clinical trial failures. 

     



Related content

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »